Citations

Institution: Mayo Clinic Clear

Showing 10 of 108135 citations.

A Multi‐Center Study of Ossiculoplasty Hearing Outcomes and a Grading Scale of Ear Environment Risk
Gluth, Michael B. , Judd, Ryan T. , Gurgel, Richard K. , Dornhoffer, John L., Kutz, Joe Walter , Carlson, Matthew L. , Kuthubutheen, Jafri , Anderson, Ryan D., Killeen, Daniel E. , Barnes, Jason H. , Fussell, Wanda L., Jeganathan, Chaithanya, Kutz, Walter , Gurgel, Richard Klaus , Anderson, Ryan D., Jeganathan, Chaithanya

The Laryngoscope | December 23, 2024 | Volume: 135 | Issue: S2 | Pages: No page available

10.1002/lary.31965 | PMID 39714957 Get It

ObjectiveTo determine which ear environment risk factors impact ossiculoplasty hearing outcomes and to generate a statistically‐valid grading system for ossiculoplasty outcome reporting.Study TypeRetrospective case series.MethodsA multi‐institutional database was generated from cases performed between 2011 and 2019. Preoperative and postoperative hearing thresholds were recorded alongside potential ear environment risk factors. Multiple variable linear regression statistical analyses of risk factors were applied to determine independent association with postoperative pure tone average air‐bone gap (PTA‐ABG). Significant factors were used to generate a statistically‐weighted grading scale of Ear Environment Risk (EER).Results1679 cases had a mean follow‐up time of 33.6 months (SD 36.3) and a mean postoperative PTA‐ABG of 21.2 (SD 12.8). Multiple revision status (p < 0.001), presence of canal wall down mastoidectomy cavity (p = 0.020), absent malleus (p < 0.001), absent stapes superstructure (p = 0.016), frequent otorrhea (p = 0.008), pediatric age (p < 0.001), and blunted/lateralized tympanic membrane (p = 0.003) were independently correlated with PTA‐ABG. These factors were incorporated into an EER Scoring System with four distinct risk groups wherein each risk group was significantly correlated with PTA‐ABG, and this grading system was better correlated with PTA‐ABG (Kendall's τ = 0.193) than other existing published grading scales.ConclusionGrading environment risk according to a novel EER scoring system generates meaningful risk groupings that correlate with ossiculoplasty postoperative PTA‐ABG, and this holds potential to frame reporting of hearing outcomes for future ossiculoplasty research.Level of Evidence3 Laryngoscope, 135:S1–S11, 2025
Fenestrated and Branched Endovascular Aortic Repair and Mortality at Hospitals Without Investigational Device Trials
Dun, Chen , Columbo, Jesse A. , Mendes, Bernardo C. , Goodney, Phillip, Schanzer, Andres, Schermerhorn, Marc L. , Makary, Martin A. , Black, James H. , Columbo, Jesse A , Zettervall, Sara L , Schanzer, Andres , Hicks, Caitlin W.

JAMA Surgery | December 23, 2024 | Volume: 160 | Issue: 2 | Pages: 153

10.1001/jamasurg.2024.5654 | PMID 39714886 Get It

ImportanceFenestrated and branched endovascular aortic repairs (F/BEVAR) have been adopted by many centers. However, national trends of F/BEVAR use remain unclear, particularly at sites who perform them without an US Food and Drug Adminstration (FDA)–approved investigational device exemption (IDE).ObjectiveTo quantify the use of F/BEVAR in the US and to determine if mortality was different at IDE vs non-IDE sites.Design, Setting, and ParticipantsThis retrospective cohort study examined 100% fee-for-service Medicare claims data from 2016 to 2023. Participants were patients who underwent endovascular treatment of the visceral aorta incorporating 2 or more visceral artery endoprostheses. Hospitals with vs without an IDE were identified using hospitals’ Employer Identification Number as a time varying exposure.ExposureF/BEVAR.Main Outcomes and MeasuresTrends in the center-level F/BEVAR case volume stratified by IDE status were assessed using cumulative incidence curves. Mortality outcomes at 30 days and 3 years were compared using Kaplan-Meier methods and Cox proportional hazards models with adjustment for baseline patient characteristics.ResultsFrom 2016 to 2023, 8017 patients were treated with F/BEVAR at 549 hospitals. The median (IQR) age was 75.8 (71.3-80.8) years; 5795 patients (72.3%) were male and 2222 (27.7%) female. A total of 2226 F/BEVAR (27.8%) were performed at 22 hospitals with an IDE. The number of patients treated with F/BEVAR increased from 771 in 2016 to 1251 in 2023. The median (IQR) annual case volume per hospital was significantly higher at IDE sites (22.3 [11.0-30.4] vs 1.2 [1.0-2.0] cases/y; P &amp;lt; .001); 18 IDE sites (90.0%) and 20 non-IDE sites (3.7%) completed 9 or more cases per year. The 30-day mortality (3.0% vs 4.9%) but not 3-year mortality (26.0% vs 27.1%) was lower for patients treated at hospitals with vs without an IDE. After risk adjustment, both 30-day (odds ratio, 0.47; 95% CI, 0.32-0.69) and midterm mortality (hazard ratio, 0.81; 95% CI, 0.69-0.95) were lower for patients treated at IDE sites.Conclusions and RelevanceThe use of F/BEVAR is increasing across the United States, with the majority of cases being performed outside of IDE studies and at low-volume centers. F/BEVAR performed at non-IDE centers are associated with higher adjusted 30-day and midterm mortality. Transparent outcome reporting and identification of process measures from IDE sites may help achieve more equity in patient outcomes.
Longitudinal Glioma Monitoring via Cerebrospinal Fluid Cell-Free DNA
Riviere-Cazaux, Cécile , Dong, Xiaoxi , Mo, Wei , Kumar, Rahul , Dai, Chao , Carlstrom, Lucas P. , Munoz-Casabella, Amanda , Nesvick, Cody L. , Andersen, Katherine M., Hoplin, Matthew D. , Canaday, Nicholas, Jusué-Torres, Ignacio , Malik, Noor , Campian, Jian L., Ruff, Michael W. , Uhm, Joon H. , Eckel‐Passow, Jeanette E. , Kizilbash, Sani H. , Warrington, Arthur E. , Jenkins, Robert B. , Du, Pan , Jia, Shidong , Ghadimi, Keyvan , Nesvick, Cody L , Andersen, Katherine M , Hoplin, Matthew D , Canaday, Nicholas , Jusue-Torres, Ignacio , Malik, Noor , Campian, Jian L , Ruff, Michael W , Uhm, Joon H , Eckel-Passow, Jeanette E , Kaufmann, Timothy J , Routman, David M , Kizilbash, Sani H , Sener, Ugur , Warrington, Arthur E , Jenkins, RB , Du, Pan , Jia, Shidong , Burns, Terry C , Kumar, Rahul , Kaufmann, Timothy J. , Routman, David M. , Sener, Uğur , Burns, Terry C.

Clinical Cancer Research | December 23, 2024 | Volume: 31 | Issue: 5 | Pages: 881-889

10.1158/1078-0432.ccr-24-1814 | PMID 39715486 Get It

Abstract Purpose: Current methods for glioma response assessment are limited. This study aimed to assess the technical and clinical feasibility of molecular profiling using longitudinal intracranial cerebrospinal fluid (CSF) from patients with gliomas. Experimental Design: Adults with gliomas underwent longitudinal intracranial CSF collection via Ommaya reservoirs or ventriculoperitoneal shunts. Cell-free DNA (cfDNA) was extracted and analyzed using PredicineCARE for cancer variant profiling and/or PredicineSCORE for low-pass whole-genome sequencing. Results: Five patients (two females and three males; median age, 40 years; range, 32–64 years) underwent longitudinal intracranial CSF collection via Ommaya reservoirs (n = 4) or ventriculoperitoneal shunts (n = 1). In total, 47 CSF samples were obtained (median volume, 4.00 mL; 0.5–5 mL). Forty-one samples (87.2%) yielded sufficient cfDNA for testing. Patient-specific tumor-associated variant allelic frequencies (VAF), and thus tumor fraction, decreased in pre- versus postchemoradiation samples, including through pseudoprogression. These also increased with radiographic progression in three patients, although identifying the time of definitive disease progression from MRIs was a significant limitation. In two patients with isocitrate dehydrogenase (IDH)–mutant gliomas, decreasing IDH1 VAF after resection and chemoradiation correlated with decreased CSF D-2-hydroxyglutarate levels (0.64× and 0.62×, respectively, for the first patient and 0.01× and 0.07× for the other patient), although D-2-hydroxyglutarate and IDH1 VAF were not concordant in one patient thereafter. Moreover, the copy-number burden decreased below the limit of quantification during treatment and increased above the limit at progression. Conclusions: Longitudinal intracranial CSF cfDNA can be obtained in patients with gliomas during their disease course. However, before deploying this technique, numerous questions and challenges should be answered.
Changes in breast cancer risk associated with benign breast disease from 1967 to 2013
Degnim, Amy C. , Ghosh, Karthik , Vierkant, Robert A. , Winham, Stacey J. , Hoskin, Tanya L. , Carter, Jodi M. , McCauley, Bryan M. , Jensen, Matt R., Allers, Teresa, Frost, Marlene H., Gehling, Denice, Fischer, Jessica, Seymour, Lisa R. , Denison, Lori A., Vachon, Celine M. , Hartmann, Lynn C. , Frost, Marlene, Gehling, Denice L, Fischer, Jessica L, Pacheco-Spann, Laura M , Rosenberg, Philip S , Vachon, Celine M. , Radisky, Derek C , Sherman, Mark E , Winham, Stacey J , Degnim, Amy C , Vierkant, Robert A , Hoskin, Tanya , Carter, Jodi , Pacheco-Spann, Laura M. , Rosenberg, Philip S. , Radisky, Derek C. , Sherman, Mark E.

JNCI Cancer Spectrum | December 23, 2024 | Volume: 9 | Issue: 1 | Pages: No page available

10.1093/jncics/pkae128 | PMID 39786446 Get It

Abstract Background Benign breast disease (BBD) increases breast cancer (BC) risk progressively for women diagnosed with nonproliferative change, proliferative disease without atypia (PDWA), and atypical hyperplasia (AH). Leveraging data from 18 704 women in the Mayo BBD Cohort (1967-2013), we evaluated temporal trends in BBD diagnoses and how they have influenced associated BC risk over 4 decades. Methods BC risk trends associated with BBD were evaluated using standardized incidence ratios (SIRs) and age–period–cohort modeling across 4 eras—premammogram (1967-1981), precore needle biopsy (CNB) (1982-1992), transition to CNB (1993-2001), and CNB era (2002-2013). Results With a median follow-up of 15.8 years, 9.9% of women were diagnosed with BC (invasive and/or DCIS). From the premammogram era to the CNB era, we observed a significant increase in BC risk, rising from an SIR of 1.61 to 1.99. The proportion of proliferative BBD diagnoses (PDWA or AH) increased markedly over time (28.1%-49.7%), as did the proportion of DCIS events (11%-28%; χ2 P &lt; .001). Within specific BBD categories, the risk of invasive BC increased modestly. Conclusions Absolute risk of BC within BBD categories remained stable, but the relative risk of BC after BBD increased over time due to notable increases in higher risk BBD lesions, specifically PDWA and AH. These findings illustrate how evolving screening practices have changed the risk profile of BBD and should inform management strategies for patients with BBD in modern clinical settings.
Narrow, Broad, and Future Considerations for Populations with Non-English Language Preference
Chipman, S , Meagher, Karen M. , Barwise, Amelia , Chipman, Samantha Aubrey , Barwise, Amelia K , Meagher, Karen M

The American Journal of Bioethics | December 23, 2024 | Volume: 25 | Issue: 1 | Pages: No page available

10.1080/15265161.2024.2441738 | PMID 39714250 Get It

Outcomes Following Direct Anterior Approach Total Hip Arthroplasty
Wilson, Jacob M. , Hadley, Matthew L. , Ledford, Cameron K. , Bingham, Joshua S. , Wyles, Cody C. , Taunton, Michael J. , Wyles, Cody C , Taunton, Michael J , Bingham, Joshua S , Ledford, Cameron K , Larson, Dirk R.

Journal of Bone and Joint Surgery | December 23, 2024 | Volume: 107 | Issue: 4 | Pages: 356-363

10.2106/jbjs.24.00132 | PMID 39715296 Get It

Background: The direct anterior approach (DAA) is a popular approach for primary total hip arthroplasty (THA). However, the contemporary outcomes for DAA THA need further elucidation. Therefore, we aimed to describe implant survivorship, complications, and clinical outcomes after DAA THA. Methods: From our multi-institutional total joint registry, 3,184 patients who had undergone 3,698 primary DAA THA between 2010 and 2019 were identified. The identified patients had a mean age of 65 years and a mean body mass index (BMI) of 29 kg/m 2 , and 53% of patients were female. The indications for revision and reoperation and the incidence of complications were collected and analyzed. Potential risk factors, including age, sex, BMI, and high-volume compared with low-volume operating surgeons, were examined. Descriptive statistics and Kaplan-Meier survivorship with Cox regression analyses were performed. Results: At 10 years following primary DAA THA, the cohort had 96% (95% confidence interval [CI], 95% to 98%) survivorship free of any revision and 94% (95% CI, 92% to 96%) survivorship free of any reoperation. The leading indications for revision were periprosthetic joint infection (PJI) (n = 24; 5-year cumulative incidence, 0.93% [95% CI, 0.6% to 1.5%]), periprosthetic fracture (n = 20; 5-year cumulative incidence, 0.62% [95% CI, 0.4% to 1.0%]), and aseptic loosening (n = 14; 11 femoral, 3 acetabular; 5-year cumulative incidence, 0.84% [95% CI, 0.5% to 1.5%]). A BMI of ≥40 kg/m 2 was found to be significantly associated with PJI (hazard ratio [HR], 6.4; p < 0.001), reoperation (HR, 3.5; p < 0.001), and nonoperative complications (HR, 2.3; p = 0.018). Survivorship free of recurrent instability was 99.6% (95% CI, 99.4% to 99.8%) at 5 and 10 years, and the cumulative incidence of revision for instability was 0.14% at 5 years. Conclusions: In one of the largest published series to date, survivorship following DAA THA was satisfactory at early to intermediate follow-up. The leading indications for revision were PJI, periprosthetic fracture, and aseptic loosening. Instability after DAA THA was uncommon and infrequently led to revision. As a note of caution, a BMI of ≥40 kg/m 2 was identified as a risk factor for adverse outcome after DAA THA. Level of Evidence: Therapeutic Level IV . See Instructions for Authors for a complete description of levels of evidence.
Seeing the Road Ahead—The Need to Address Accessibility of Diabetes Technology
Kartik, R , Aktürk, Halis Kaan , Stewart, Michael W., Forlenza, Gregory P. , Kartik, Rishika , Forlenza, Gregory P

Diabetes Technology & Therapeutics | December 23, 2024 | Volume: 27 | Issue: 4 | Pages: 245-247

10.1089/dia.2024.0412 | PMID 39714954 Get It

Rates of School Absences in Pediatric Scoliosis Patients and Work Absences in Their Parents/Caregivers: A Retrospective Analysis
Paradkar, Ria, Regan, Christina , Nolte, Charles P. , Stans, Anthony A. , Shaughnessy, William J. , Milbrandt, Todd A. , Larson, A. Noelle , Stans, Anthony, Shaughnessy, William, Mulford, Kellen, Larson, A Noelle , Paradkar, Ria , Mulford, Kellen L.

Journal of Clinical Medicine | December 23, 2024 | Volume: 13 | Issue: 24 | Pages: 7859

10.3390/jcm13247859 | PMID 39768783 Get It

Background/Objectives: The burden of scoliosis care extends beyond treatment costs and includes missed school for patients and lost income for parents. Chronic absenteeism, defined as more than 18 days of missed school, can have a significant impact on a child’s educational progression, but missed school and work due to scoliosis treatment are not well quantified in the literature. This study investigates absenteeism among scoliosis patients and their caregivers. Methods: We conducted a retrospective comparative study of survey results based on surgery timing and surgery type. Patients and caregivers presenting for clinic visits for scoliosis treatment at a single large tertiary care center from 2014 to 2022 were queried. Results: We collected 2772 surveys from 1104 unique patients. Of these, 223 surveys from 132 patients were within one year of surgery: 140 post-fusion surveys, 71 post-nonfusion surveys, and 11 post-halo/multistage surgery surveys. A total of 2280 surveys were from 1022 nonoperatively treated patients. School absenteeism was significantly higher for surgeries during the school year compared to summer in both the fusion and nonfusion groups, though work absenteeism showed no significant differences. Halo/multistage surgery patients had the highest rates of absenteeism. Conclusions: This study highlights the impacts of scoliosis surgery timing and type on absenteeism among patients and their caregivers. Surgery during summer breaks reduces school absenteeism and academic disruption. Halo/multistage surgery patients face the greatest risk of chronic absenteeism from school, indicating a need for targeted interventions. Optimized surgical timing and planning can help families navigate the educational and financial challenges of scoliosis treatment.
Advances in Atrial Fibrillation Management: A Guide for General Internists
Pham, Hoang Nhat , Ibrahim, Ramzi , Hieu, Truong Hong , Sainbayar, Enkhtsogt , Tran, Viet Nghi , Abdelnabi, Mahmoud , Kanaan, Christopher , Sridharan, Aadhavi , Truong, Hieu Hong , Nhat, Hoang , Ibrahim, Ramzi

Journal of Clinical Medicine | December 23, 2024 | Volume: 13 | Issue: 24 | Pages: 7846

10.3390/jcm13247846 | PMID 39768769 Get It

Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia, impacting approximately 6.1 million adults in the United States, with projections to increase two-fold by 2030. AF significantly increases the risk of stroke and other adverse cardiovascular events, leading to increased morbidity and mortality. The 2023 ACC/AHA/ACCP/HRS guidelines present a paradigm shift in AF management, moving from a duration-based classification to a more comprehensive, patient-centered approach. This includes a novel AF classification system that emphasizes early detection and intervention, including risk factors and lifestyle modification tailored to each patient’s risk profile. Moreover, the recommendations advocate for a multidisciplinary care model, ensuring coordinated management involving primary care providers and specialists. Primary care providers play a crucial role in initiating risk factor management and lifestyle interventions, even before the development of AF. This review aims to thoroughly examine the guidelines for the diagnosis and management of AF and equip general internists with the necessary insights to navigate the evolving landscape of AF care effectively.